Country of origin determination for a Neurological Sponge; 19 CFR 102.21(c)(2)
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The country of origin determination for four neurological sponges packed for retail sale will be addressed in NY N353972.
- The applicable subheading for the neuro sponge strips will be 6307.90.9891, HTSUS, which provides for “Other made up articles, including dress patterns: Other: Other: Other: Other: Other.” The rate of duty will be 7 percent ad valorem.
Ruling text
In your letter dated September 19, 2025, you requested a country of origin determination for five neuro sponges. The country of origin determination for four neurological sponges packed for retail sale will be addressed in NY N353972. This letter will address item SDP-56S, non-sterilized sponge strips imported in bulk, sterilized, and repackaged after importation. Samples were provided to this office and will be returned as per your request.
The sample, item SDP-56S, described as a “Neutec Neuro,” is a single-use, disposable textile sponge designed to protect the neurological tissue and absorb blood or fluid during neurosurgery. The single layer strip shaped sponge is composed of 100 percent rayon nonwoven fabric coated on both sides with an acrylic resin. The coating is not visible to the naked eye.
The sponge strip, measuring ¼ inch in width by 3 inches in length, features a 3-inch-long green barium sulfate monofilament sonically welded to the center of the fabric to facilitate X-ray detection and to help prevent the item from being left in the patient’s body. The sponge strip also features an 11 to 12-inch-long 100 percent cotton dyed blue thread sewn to the top of the sponge for ease in visibility and identification.
Ten non-sterilized sponge strips are wound onto an accountability card (winding card) and placed in an unsealed glassine bag. You state that the non-sterilized sponge strips will be imported into the United States in bulk, sold and exported to a Canadian company for sterilization and final packaging. The sterilized products may remain in Canada, or enter another country’s market, or return to a U.S. warehouse and be distributed to hospitals and other healthcare facilities.
You also stated that the sponge strips might have a green thread sewn to the top of the sponge for ease in visibility or identification.
You state the manufacturing operations for the neurological sponge are as follows: United States: • 100 percent cotton dyed blue thread is produced and shipped in spools to Dominican Republic. • 100 percent rayon nonwoven griege fabric is produced. • The 100 percent rayon nonwoven greige fabric is coated on both sides and shipped in rolls to Dominican Republic. • The green barium sulfate monofilament strip is produced and shipped in spools to Dominican Republic.
Thailand: • 100 percent polyester thread is produced and shipped in spools to Dominican Republic.
Dominican Republic: • 100 percent polyester thread is braided and dyed green in the Dominican Republic. • The roll of nonwoven fabric is slit into different widths. • The green barium sulfate monofilament is sonically welded to the fabric. • The fabric is cut into different lengths of sponge strips. • The blue cotton thread or green polyester thread is sewn to the fabric. • Ten non-sterile neurological sponge strips with cotton or polyester thread are wound onto an accountability card (winding card). • Each accountability card is inspected and placed in an individual unsealed glassine bag. • 100 unsealed glassine bags are placed in a polybag, packaged in a carton, and shipped to the United States.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N354701).